NCT02259075View on ClinicalTrials.gov

Botox Injection in Treatment of Chronic Migraine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Migraine Disorders
Interventions
DRUG

Botulinum Toxin Type A

Trial Locations (1)

Unknown

Department of Neuroscience, Norwegian University of Science and Technology, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT02259075 - Botox Injection in Treatment of Chronic Migraine | Biotech Hunter | Biotech Hunter